OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
YAR$534.2059

Yara International ASA

Agricultural ChemicalsVerified

Yara International ASA maintains a capital structure with a debt-to-equity ratio of 0.61, indicating a moderate reliance on debt financing. The company's liquidity position is characterized by a current ratio of 1.71, suggesting it has sufficient short-term assets to cover its short-term liabilities. However, the company's free cash flow is negative at -117 million USD, which may signal potential challenges in funding operations and growth initiatives without external financing. In terms of profitability, Yara's return on equity (ROE) and return on assets (ROA) are both at 0.0001, which is significantly below the industry median for Agricultural Chemicals. This suggests that the company is not generating returns that are in line with its peers. The operating margin, calculated as operating income divided by revenue, is 6.05%, which is also below the industry median, indicating that the company's operational efficiency is lagging. Geographically, Yara's revenue is concentrated in a few key markets, with the majority of its sales coming from Europe and the Americas. This concentration may expose the company to regional economic downturns or regulatory changes that could impact its overall performance. The company's exposure to these regions is a strategic choice, but it also introduces a level of risk that is not diversified across a broader geographic footprint. Looking at the company's growth trajectory, Yara's revenue has shown a decline in recent periods, and the outlook for the current fiscal year is not optimistic. The company is expected to see a contraction in revenue, with a negative delta projected for the next fiscal year. This trend is concerning, as it suggests that the company may be losing market share or facing declining demand in its core markets. The risk assessment for Yara highlights several key concerns. The company's liquidity risk is rated as medium, primarily due to its negative net cash position after accounting for total debt. Additionally, the risk of dilution is considered low, but the company's capital structure and financial performance may necessitate future equity issuances to fund operations or reduce debt. The company's recent financial performance and outlook suggest that it may need to take corrective actions to stabilize its financial position and improve its profitability. Recent events, including analyst estimates and recommendations, provide insight into the market's perception of Yara. The mean price target is 520.17 USD, with a median of 530.00 USD, indicating a generally cautious outlook. The mean recommendation of 2.77 suggests a mixed sentiment among analysts, with a significant number of "hold" ratings. These signals may influence investor behavior and the company's stock price in the near term.

30-day price · YAR-71.60 (-13.4%)
Low$464.20High$565.60Close$464.20As of9 Jun, 00:00 UTC
Profile
CompanyYara International ASA
TickerYAR.OL
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryAgricultural Chemicals
AI analysis

Business. Yara International ASA is a global leader in the production and distribution of nitrogen-based fertilizers, primarily serving the agricultural sector.

Classification. Yara is classified under the Basic Materials economic sector, Chemicals business sector, and Agricultural Chemicals industry with a confidence level of 0.92.

Yara International ASA maintains a capital structure with a debt-to-equity ratio of 0.61, indicating a moderate reliance on debt financing. The company's liquidity position is characterized by a current ratio of 1.71, suggesting it has sufficient short-term assets to cover its short-term liabilities. However, the company's free cash flow is negative at -117 million USD, which may signal potential challenges in funding operations and growth initiatives without external financing. In terms of profitability, Yara's return on equity (ROE) and return on assets (ROA) are both at 0.0001, which is significantly below the industry median for Agricultural Chemicals. This suggests that the company is not generating returns that are in line with its peers. The operating margin, calculated as operating income divided by revenue, is 6.05%, which is also below the industry median, indicating that the company's operational efficiency is lagging. Geographically, Yara's revenue is concentrated in a few key markets, with the majority of its sales coming from Europe and the Americas. This concentration may expose the company to regional economic downturns or regulatory changes that could impact its overall performance. The company's exposure to these regions is a strategic choice, but it also introduces a level of risk that is not diversified across a broader geographic footprint. Looking at the company's growth trajectory, Yara's revenue has shown a decline in recent periods, and the outlook for the current fiscal year is not optimistic. The company is expected to see a contraction in revenue, with a negative delta projected for the next fiscal year. This trend is concerning, as it suggests that the company may be losing market share or facing declining demand in its core markets. The risk assessment for Yara highlights several key concerns. The company's liquidity risk is rated as medium, primarily due to its negative net cash position after accounting for total debt. Additionally, the risk of dilution is considered low, but the company's capital structure and financial performance may necessitate future equity issuances to fund operations or reduce debt. The company's recent financial performance and outlook suggest that it may need to take corrective actions to stabilize its financial position and improve its profitability. Recent events, including analyst estimates and recommendations, provide insight into the market's perception of Yara. The mean price target is 520.17 USD, with a median of 530.00 USD, indicating a generally cautious outlook. The mean recommendation of 2.77 suggests a mixed sentiment among analysts, with a significant number of "hold" ratings. These signals may influence investor behavior and the company's stock price in the near term.
Key takeaways
  • Yara's capital structure is moderately leveraged, with a debt-to-equity ratio of 0.61 and a current ratio of 1.71.
  • The company's profitability metrics, including ROE and ROA, are significantly below industry medians, indicating operational inefficiencies.
  • Revenue is concentrated in Europe and the Americas, exposing the company to regional economic and regulatory risks.
  • The company is expected to see a decline in revenue for the current and next fiscal years, signaling potential market share loss or declining demand.
  • Analysts have a mixed outlook, with a mean recommendation of 2.77 and a range of price targets from 330.00 to 619.00 USD.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue$3.52B
Gross profit$924.0M
Operating income$213.0M
Net income$1.0M
R&D
SG&A
D&A
SBC
Operating cash flow$880.0M
CapEx-$521.0M
Free cash flow-$117.0M
Total assets$15.95B
Total liabilities$8.69B
Total equity$7.26B
Cash & equivalents$872.0M
Long-term debt$4.46B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$16.62B$1.07B$449.0M-$705.0M
FY-3$23.90B$3.83B$2.78B$1.73B
FY-2$15.51B$392.0M$49.0M-$1.46B
FY-1$13.87B$686.0M$13.0M-$142.0M
FY0$15.62B$1.57B$1.37B$1.38B
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$17.27B$7.10B$394.0M
FY-3$17.98B$8.59B$1.01B
FY-2$16.03B$7.55B$539.0M
FY-1$14.99B$6.99B$317.0M
FY0$17.14B$8.72B$913.0M
PeriodOCFCapExFCFSBC
FY-4$1.41B-$858.0M-$705.0M
FY-3$2.39B-$958.0M$1.73B
FY-2$2.29B-$1.21B-$1.46B
FY-1$1.29B-$1.08B-$142.0M
FY0$1.89B-$946.0M$1.38B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$3.52B$213.0M$1.0M-$117.0M
FQ-6$3.63B$309.0M$285.0M$279.0M
FQ-5$3.40B-$3.0M-$291.0M-$313.0M
FQ-4$3.62B$308.0M$294.0M$279.0M
FQ-3$3.94B$351.0M$411.0M$369.0M
FQ-2$4.11B$470.0M$320.0M$377.0M
FQ-1$3.95B$442.0M$344.0M$353.0M
FQ0$4.22B$610.0M$326.0M$366.0M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$15.95B$7.26B$872.0M
FQ-6$16.37B$7.67B$907.0M
FQ-5$14.99B$6.99B$317.0M
FQ-4$15.67B$7.51B$326.0M
FQ-3$16.90B$8.06B$837.0M
FQ-2$16.99B$8.40B$927.0M
FQ-1$17.14B$8.72B$913.0M
FQ0$17.81B$9.09B$1.22B
PeriodOCFCapExFCFSBC
FQ-7$880.0M-$521.0M-$117.0M
FQ-6$1.19B-$794.0M$279.0M
FQ-5$1.29B-$1.08B-$313.0M
FQ-4$329.0M-$266.0M$279.0M
FQ-3$1.21B-$458.0M$369.0M
FQ-2$1.55B-$675.0M$377.0M
FQ-1$1.89B-$946.0M$353.0M
FQ0$525.0M-$246.0M$366.0M
Valuation
Market price$534.20
Market cap$136.07B
Enterprise value$139.66B
P/E136074.4
Reported non-GAAP P/E
EV/Revenue39.6
EV/Op income655.7
EV/OCF158.7
P/B18.8
P/Tangible book18.8
Tangible book$7.26B
Net cash-$3.59B
Current ratio1.7
Debt/Equity0.6
ROA0.0%
ROE0.0%
Cash conversion880.0%
CapEx/Revenue-14.8%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Agricultural Chemicals · cohort 80 companies
MetricYARActivity
Op margin6.0%6.4% medp25 2.4% · p75 11.2%below median
Net margin0.0%4.3% medp25 1.2% · p75 8.5%bottom quartile
Gross margin26.2%17.4% medp25 12.5% · p75 23.5%top quartile
CapEx / revenue-14.8%-5.3% medp25 -10.7% · p75 -3.3%bottom quartile
Debt / equity61.0%24.2% medp25 7.7% · p75 88.6%above median
Observations
IR observations
Mean price target520.17 USD
Median price target530.00 USD
High price target619.00 USD
Low price target330.00 USD
Mean recommendation2.77 (1=strong buy, 5=strong sell)
Strong-buy count4.00
Buy count1.00
Hold count13.00
Sell count4.00
Strong-sell count0.00
Mean EPS estimate6.81 USD
Last actual EPS4.42 USD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history
no public URL
2026-05-01 09:53 UTC#b2829ba0
Market quoteclose USD 539.00 · shares 0.25B diluted
no public URL
2026-05-01 09:53 UTC#88d5a51c
Source: analysis-pipeline (hybrid)Generated: 2026-05-30 02:24 UTCJob: bdde901d